Provided herein are compounds, such as a compound of Formula (I), or a pharmaceutically acceptable salt thereof, that are immunoproteasome (such as LMP2 and LMP7) inhibitors. The compounds described herein can be useful for the treatment of diseases treatable by inhibition of immunoproteasomes. Also provided herein are pharmaceutical compositions containing such compounds and processes for preparing such compounds.
US9573958B2
申请人:——
公开号:US9573958B2
公开(公告)日:2017-02-21
Ibarra, Carlos Alvarez; Cuervo, Rocio; Fernandez-Monreal, Maria C., Journal of the Chemical Society. Perkin transactions I, 1991, # 6, p. 1473 - 1477
作者:Ibarra, Carlos Alvarez、Cuervo, Rocio、Fernandez-Monreal, Maria C.、Garcia, Marta、Ruiz, Maria P.、Eliel, Ernest L.